Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories

de Jongh, Reinoud, Bolt, Ineke, Schermer, Maartje, Olivier, Berend · 2008 · Neuroscience & Biobehavioral Reviews

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2007.12.001

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 72

  1. Avery, 2000, The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task, Neuropsychopharmacology, 23, 240, 10.1016/S0893-133X(00)00111-1 · DOI
  2. Barco, 2003, CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects, Expert. Opin. Ther. Targets., 7, 101, 10.1517/14728222.7.1.101 · DOI · Paper page
  3. Beglinger, 2004, Neuropsychological test performance in healthy volunteers before and after donepezil administration, J. Psychopharmacol, 18, 102, 10.1177/0269881104040248 · DOI
  4. Beglinger, 2005, Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study, J. Clin. Psychopharmacol., 25, 159, 10.1097/01.jcp.0000155822.51962.b4 · DOI
  5. Beracochea, 2003, Enhancement of learning processes following an acute modafinil injection in mice, Pharmacol. Biochem. Behav., 76, 473, 10.1016/j.pbb.2003.09.007 · DOI
  6. Bolt, L.L.E., 2007. True to oneself? Broad and narrow ideas on authenticity in the enhancement debate. Theoretical Medicine and Bioethics (in press). · DOI
  7. Bostrom, 2003, Human Genetic Enhancements: A Transhumanist Perspective, The Journal of Value Inquiry, 37, 493, 10.1023/B:INQU.0000019037.67783.d5 · DOI
  8. Bostrom, 2005, In defense of posthuman dignity, Bioethics, 19, 202, 10.1111/j.1467-8519.2005.00437.x · DOI · Paper page
  9. Cahill, 2000, Impaired memory consolidation in rats produced with beta-adrenergic blockade, Neurobiol. Learn. Mem., 74, 259, 10.1006/nlme.1999.3950 · DOI
  10. Caldwell, 2000, A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study, Psychopharmacology (Berl), 150, 272, 10.1007/s002130000450 · DOI · Paper page
  11. Carlezon, 2005, The many faces of CREB, Trends. Neurosci., 28, 436, 10.1016/j.tins.2005.06.005 · DOI · Paper page
  12. Debiec, 2004, Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala, Neuroscience, 129, 267, 10.1016/j.neuroscience.2004.08.018 · DOI · Paper page
  13. DeGrazia, 2000, Prozac, Enhancement, and Self-Creation, Hastings Center Report, 30, 34, 10.2307/3528313 · DOI · Paper page
  14. Domes, 2007, Oxytocin improves “mind-reading” in humans, Biol. Psychiatry., 61, 731, 10.1016/j.biopsych.2006.07.015 · DOI · Paper page
  15. Egan, 2001, Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia, Proc. Natl. Acad. Sci. USA, 98, 6917, 10.1073/pnas.111134598 · DOI · Paper page
  16. Elliott, 2007, Against happiness, Medicine, Health Care and Philosophy, 10, 167, 10.1007/s11019-007-9058-2 · doi:10.1007/s11019-007-9058-2
  17. Farah, 2002, Emerging ethical issues in neuroscience, Nature Neuroscience, 5, 1123, 10.1038/nn1102-1123 · DOI · Paper page
  18. Farah, 2005, Neuroethics: the practical and the philosophical, Trends Cogn. Sci., 9, 34, 10.1016/j.tics.2004.12.001 · DOI · Paper page
  19. Furlan, 2004, SSRIs do not cause affective blunting in healthy elderly volunteers, Am. J. Geriatr. Psychiatry., 12, 323, 10.1097/00019442-200405000-00012 · DOI
  20. Gibbs, 2005, A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory, Psychopharmacology (Berl), 180, 644, 10.1007/s00213-005-0077-5 · DOI · Paper page
  21. Glannon, 2006, Psychopharmacology and memory, J. Med. Ethics., 32, 74, 10.1136/jme.2005.012575 · DOI
  22. Gron, 2005, Cholinergic enhancement of episodic memory in healthy young adults, Psychopharmacology (Berl), 182, 170, 10.1007/s00213-005-0043-2 · DOI
  23. Honey, 2003, Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory, Neuropsychopharmacology, 28, 2037, 10.1038/sj.npp.1300272 · DOI
  24. Hou, 2005, Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers, Psychopharmacology (Berl), 181, 537, 10.1007/s00213-005-0013-8 · DOI
  25. Ingvar, 1997, Enhancement by an ampakine of memory encoding in humans, Exp. Neurol., 146, 553, 10.1006/exnr.1997.6581 · DOI · Paper page
  26. Ishizuka, 2003, Modafinil increases histamine release in the anterior hypothalamus of rats, Neurosci. Lett., 339, 143, 10.1016/S0304-3940(03)00006-5 · DOI
  27. Jakala, 1999, Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans, Neuropsychopharmacology, 20, 119, 10.1016/S0893-133X(98)00055-4 · DOI · Paper page
  28. Jakala, 1999, Guanfacine, but not clonidine, improves planning and working memory performance in humans, Neuropsychopharmacology, 20, 460, 10.1016/S0893-133X(98)00127-4 · DOI · Paper page
  29. Josselyn, 2001, Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala, J. Neurosci., 21, 2404, 10.1523/JNEUROSCI.21-07-02404.2001 · DOI · Paper page
  30. Kimberg, 2003, Cognitive effects of the dopamine receptor agonist pergolide, Neuropsychologia, 41, 1020, 10.1016/S0028-3932(02)00317-2 · DOI
  31. Kimberg, 1997, Effects of bromocriptine on human subjects depend on working memory capacity, Neuroreport, 8, 3581, 10.1097/00001756-199711100-00032 · DOI · Paper page
  32. Kimberg, 2001, Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI, Hum. Brain. Mapp., 12, 246, 10.1002/1097-0193(200104)12:4<246::AID-HBM1019>3.0.CO;2-9 · DOI
  33. Konrad, 2004, Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder, J. Am. Acad. Child. Adolesc. Psychiatry., 43, 191, 10.1097/00004583-200402000-00015 · DOI · Paper page
  34. Lynch, 2006, Glutamate-based therapeutic approaches: ampakines, Curr. Opin. Pharmacol., 6, 82, 10.1016/j.coph.2005.09.005 · DOI · Paper page
  35. Lynch, 1997, Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans, Exp. Neurol., 145, 89, 10.1006/exnr.1997.6447 · DOI · Paper page
  36. Matsuoka, 1996, D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys, J. Pharmacol. Exp. Ther., 278, 891
  37. McCabe, 2004, Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001, J. Adolesc. Health, 35, 501, 10.1016/j.jadohealth.2004.02.004 · DOI
  38. McCabe, 2005, Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey, Addiction, 100, 96, 10.1111/j.1360-0443.2005.00944.x · DOI · Paper page
  39. Mehlman, 2004, Cognition-Enhancing Drugs, The Milbank Quarterly, 82, 483, 10.1111/j.0887-378X.2004.00319.x · DOI
  40. Moynihan, 2006, The Fight Against Disease Mongering: Generating Knowledge for Action, PLoS Medicine, 3, 425, 10.1371/journal.pmed.0030191 · DOI · Paper page
  41. Müller, 1998, D1- versus D2-receptor modulation of visuospatial working memory in humans, J. Neurosci., 18, 2720, 10.1523/JNEUROSCI.18-07-02720.1998 · DOI · Paper page
  42. Müller, 2004, Effects of modafinil on working memory processes in humans, Psychopharmacology (Berl), 177, 161, 10.1007/s00213-004-1926-3 · DOI · Paper page
  43. Mumenthaler, 2003, Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects, Neuropsychopharmacology, 28, 1366, 10.1038/sj.npp.1300202 · DOI
  44. Nolan, 2004, COMT polymorphism in schizophrenia: Differential effects of Val and Met alleles on cognitive stability and flexibility, American Journal of Psychiatry, 161, 359, 10.1176/appi.ajp.161.2.359 · DOI · Paper page
  45. Parens, 2005, Authenticity and Ambivalence. Toward Understanding the Enhancement Debate, The Hastings Center Report, 35, 34, 10.2307/3528804 · doi:10.2307/3528804
  46. Porrino, 2005, Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates, PLoS Biol, 3, e299, 10.1371/journal.pbio.0030299 · DOI · Paper page
  47. Randall, 2003, Modafinil affects mood, but not cognitive function, in healthy young volunteers, Hum. Psychopharmacol., 18, 163, 10.1002/hup.456 · DOI
  48. Randall, 2004, The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers, Pharmacol. Biochem. Behav., 77, 547, 10.1016/j.pbb.2003.12.016 · DOI
  49. Randall, 2005, Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?, J. Clin. Psychopharmacol., 25, 175, 10.1097/01.jcp.0000155816.21467.25 · DOI
  50. Randall, 2005, Cognitive effects of modafinil in student volunteers may depend on IQ, Pharmacol. Biochem. Behav., 82, 133, 10.1016/j.pbb.2005.07.019 · DOI
  51. Riedel, 2005, Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment, J. Psychopharmacol., 19, 12, 10.1177/0269881105048887 · DOI
  52. Robbins, 2006, Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition, Trends. Pharmacol. Sci., 27, 141, 10.1016/j.tips.2006.01.009 · DOI · Paper page
  53. Schermer, M., 2007. On the argument that enhancement is cheating. Journal of Medical Ethics, (in press).
  54. Schmitt, 2001, Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors, J. Psychopharmacol., 15, 173, 10.1177/026988110101500304 · DOI
  55. Shiflett, 2004, Cannabinoid inhibition improves memory in food-storing birds, but with a cost, Proc. Biol. Sci., 271, 2043, 10.1098/rspb.2004.2823 · DOI
  56. Siepmann, 2003, Effects of sertraline on autonomic and cognitive functions in healthy volunteers, Psychopharmacology (Berl), 168, 293, 10.1007/s00213-003-1448-4 · DOI
  57. Singh, 2007, Clinical implications of ethical concepts: Moral Self-Understandings of children taking methylphenidate for ADHD, Clinical Child Psychology and Psychiatry, 12, 167, 10.1177/1359104507075920 · DOI
  58. Synofzik, 2006, Kognition à la carte? Der wunsch nach kognitionsverbessernden Psychopharmaka in der Medizin, Ethik in der Medizin, 18, 37, 10.1007/s00481-006-0412-3 · DOI
  59. Takahashi, 2005, The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze, Neurosci. Lett., 380, 270, 10.1016/j.neulet.2005.01.049 · DOI
  60. Taneja, 2007, A randomized, double-blind, crossover trial of modafinil on mood, J. Clin. Psychopharmacol., 27, 76, 10.1097/jcp.0b013e31802eb7ea · DOI
  61. Tannock, 1995, Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children, J. Abnorm. Child. Psychol., 23, 235, 10.1007/BF01447091 · DOI · Paper page
  62. Teter, 2006, Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration, Pharmacotherapy, 26, 1501, 10.1592/phco.26.10.1501 · DOI · Paper page
  63. Tse, 2002, Serotonergic intervention affects both social dominance and affiliative behaviour, Psychopharmacology (Berl), 161, 324, 10.1007/s00213-002-1049-7 · DOI · Paper page
  64. Tully, 2003, Targeting the CREB pathway for memory enhancers, Nat. Rev. Drug. Discov., 2, 267, 10.1038/nrd1061 · DOI · Paper page
  65. Turner, 2003, Cognitive enhancing effects of modafinil in healthy volunteers, Psychopharmacology (Berl), 165, 260, 10.1007/s00213-002-1250-8 · DOI · Paper page
  66. Turner, 2003, Relative lack of cognitive effects of methylphenidate in elderly male volunteers, Psychopharmacology (Berl), 168, 455, 10.1007/s00213-003-1457-3 · DOI
  67. Varvel, 2002, Evaluation of CB1 receptor knockout mice in the Morris water maze, J. Pharmacol. Exp. Ther., 301, 915, 10.1124/jpet.301.3.915 · DOI · Paper page
  68. Wesensten, 2002, Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine, Psychopharmacology (Berl), 159, 238, 10.1007/s002130100916 · DOI · Paper page
  69. Wezenberg, 2007, Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers, Neuropsychopharmacology, 32, 1272, 10.1038/sj.npp.1301257 · DOI
  70. Wisor, 2005, Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil, Neuroscience, 132, 1027, 10.1016/j.neuroscience.2005.02.003 · DOI
  71. Yesavage, 2002, Donepezil and flight simulator performance: effects on retention of complex skills, Neurology, 59, 123, 10.1212/WNL.59.1.123 · DOI · Paper page
  72. Yin, 1996, CREB and the formation of long-term memory, Curr. Opin. Neurobiol., 6, 264, 10.1016/S0959-4388(96)80082-1 · DOI · Paper page

Cited by

See all 194

Metadata

Authors
de Jongh, R., Bolt, I., Schermer, M., & Olivier, B.
Venue
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Published
2008-01
Volume
32
Issue
4
Pages
760-776
ISSN
0149-7634 (ISSN-L)
OpenAlex
W2089821865
Cited by
194
References
34
FWCI
5.68
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. https://app.cochat.ai/papers/10.1016/j.neubiorev.2007.12.001
The paper
de Jongh, R., Bolt, I., Schermer, M., & Olivier, B. (2008). Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2007.12.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.